Delivering minocycline into brain endothelial cells with liposome-based technology

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 6, 2012, Pages 983-988

  Xing, Changhong ^a   Levchenko, Tatyana ^b   Guo, Shuzhen ^a   Stins, Monique ^c   Torchilin, Vladimir P ^b   Lo, Eng H ^a  

^a Neuroprotection Research Laboratory   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain endothelial cell; calpain; caspase; cell death; liposome; minocycline

Indexed keywords

BETA ACTIN; CALPAIN; CASPASE; CASPASE 3; CASPASE 7; DIPALMITOYLPHOSPHATIDYLCHOLINE; FODRIN; GELATINASE B; LIPOSOME; MACROGOL 2000; MATRIX METALLOPROTEINASE; MINOCYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN CELL; BRAIN ENDOTHELIUM CELL; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; DRUG FORMULATION; DRUG TARGETING; ENCAPSULATION; ENDOTHELIUM CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; NERVE INJURY; PRIORITY JOURNAL; STROKE; TECHNOLOGY;

ANTI-BACTERIAL AGENTS; BRAIN; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; LIPOSOMES; MATRIX METALLOPROTEINASE 9; MINOCYCLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861853815     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.48     Document Type: Article

References (15)

1. Asahi M, Rammohan R, Sumii T, Wang X, Pauw RJ, Weissig V, Torchilin VP, Lo EH (2003) Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke. J Cereb Blood Flow Metab 23:895-9 (Pubitemid 36959395)
2. Chan PH (2004) Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res 29:1943-9
3. Fagan SC, Cronic LE, Hess DC (2011) Minocycline development for acute ischemic stroke. Transl Stroke Res 2:202-8
4. Fagan SC,Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, Hall CE, Switzer JA, Ergul A, Hess DC (2010) Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke 41:2283-7
5. Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6:1045-53 (Pubitemid 350116691)
6. Hu W, Metselaar J, Ben LH, Cravens PD, Singh MP, Frohman EM, Eagar TN, Racke MK, Kieseier BC, Stuve O (2009) PEG minocycline-liposomes ameliorate CNS autoimmune disease. PLoS One 4:e4151
7. Kernt M, Hirneiss C, Neubauer AS, Kampik A (2010) Minocycline is cytoprotective in human corneal endothelial cells and induces anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP). Br J Ophthalmol 94:940-6
8. Matsukawa N, Yasuhara T, Hara K, Xu L, Maki M, Yu G, Kaneko Y, Ojika K, Hess DC, Borlongan CV (2009) Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci 10:126
9. Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH (2008) Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 39:3372-7
10. Pober JS, Min W, Bradley JR (2009) Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4:71-95
11. Ray SK, Banik NL (2003) Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:173-89
12. Rosell A, Lo EH (2008) Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 8:82-9
13. Switzer JA, Hess DC, Ergul A, Waller JL, Machado LS, Portik-Dobos V, Pettigrew LC, Clark WM, Fagan SC (2011) Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke 42:2633-5
14. Tsuji M, Wilson MA, Lange MS, Johnston MV (2004) Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 189:58-65 (Pubitemid 39024455)
15. Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74:278-85 (Pubitemid 37193714)